Karyopharm Therapeut (KPTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 250 | 229 | 387 | 634 | 152 |
| Gross Profit | 250 | 229 | 387 | 634 | 152 |
| Operating Expenses | 119,326 | 76,075 | 34,337 | 16,524 | 10,463 |
| Operating Income | -119,076 | -75,846 | -33,950 | -15,890 | -10,311 |
| Interest Expense | 0 | 1 | 0 | 0 | 0 |
| Other Income | 895 | 70 | 3 | 2 | 0 |
| Pre-tax Income | -118,181 | -75,777 | -33,947 | -15,888 | -10,311 |
| Net Income Continuous | -118,181 | -75,777 | -33,947 | -15,888 | -10,311 |
| Net Income | $-118,181 | $-75,777 | $-33,947 | $-15,888 | $-10,311 |
| EPS Basic Total Ops | -49.78 | -36.43 | -83.81 | -134.18 | -153.97 |
| EPS Basic Continuous Ops | -49.74 | -36.49 | -83.87 | -134.20 | -153.97 |
| EPS Diluted Total Ops | -49.78 | -36.43 | -83.81 | -134.18 | -153.97 |
| EPS Diluted Continuous Ops | -49.74 | -36.49 | -83.87 | -134.20 | -153.97 |
| EBITDA(a) | $-116,664 | $-75,521 | $-33,806 | $-15,768 | $-10,228 |